{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:46:18Z","timestamp":1791751578478,"version":"4.3.4"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Stichting Louise Vehmeijer"},{"name":"Stichting PPQA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immunotherapy has improved outcomes for a subset of patients with locally advanced cervical cancer. However, many tumors remain immunologically \u201ccold\u201d and fail to respond. Strategies that enhance tumor immunogenicity are therefore of increasing interest. Necroptosis, a regulated form of inflammatory cell death, has emerged as a potential mechanism capable of promoting the anti-tumor immune responses through the release of damage-associated molecular patterns and enhanced antigen presentation. In this study, we performed a systematic review and transcriptomic cross-study consensus analysis of all studies carried out describing the role and mechanisms of necroptosis occurrence in cervical cancers. We analyzed all published necroptosis-related prognostic gene signatures and integrated these findings into an exploratory transcriptomic analyses to identify mechanistic insights into interlinked biological pathways, and potential therapeutic targets. Following PRISMA guidelines, we analyzed seven published prognostic models, from studies using RNA sequencing and least absolute shrinkage and selection operator (LASSO)-based feature selection to generate a prognostic risk score for patients. We then conducted a comparative analyses of eight overlapping genes and their reported risk score coefficients. Across studies, seven necroptosis-related genes were identified, many of which are functionally linked to mitochondrial transport and permeability regulation, reactive oxygen species (ROS) generation, and inflammatory signaling. Overall, our findings support a key role for necroptosis in cervical cancer, where activation thereof is generally associated with enhanced immune infiltration and activation; thereby improved prognosis. These findings position necroptosis as a promising target for combination therapy strategies aimed at converting immunologically \u201ccold\u201d tumors into more responsive phenotypes. By integrating published signatures with exploratory analyses, we identify potential avenues to modulate necroptotic signaling in ways that may enhance synergy with immunotherapies, and have synthesized a hypothetical cell signaling and interaction diagram. Collectively, this work provides a foundation for future experimental validation and therapeutic development.<\/jats:p>","DOI":"10.1007\/s10495-026-02440-w","type":"journal-article","created":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:09:33Z","timestamp":1791702573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Necroptosis as a key player in cervical cancer progression and management: a systematic review and transcriptomic cross-study consensus analysis"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6550-4304","authenticated-orcid":false,"given":"Seth-Frerich","family":"Fobian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0561-6640","authenticated-orcid":false,"given":"Eric","family":"Eldering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2597-5986","authenticated-orcid":false,"given":"Jacqueline","family":"Tromp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6936-1934","authenticated-orcid":false,"given":"Arlene L.","family":"Oei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,11]]},"reference":[{"issue":"20","key":"2440_CR1","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","volume":"385","author":"N Colombo","year":"2021","unstructured":"Colombo N, Dubot C, Lorusso D, Caceres MV, Hasegawa K, Shapira-Frommer R et al (2021) Pembrolizumab for persistent, recurrent, or metastatic cervical cancer. N Engl J Med 385(20):1856\u20131867","journal-title":"N Engl J Med"},{"issue":"7","key":"2440_CR2","doi-asserted-by":"publisher","first-page":"101924","DOI":"10.1016\/j.ijgc.2025.101924","volume":"35","author":"X Mei","year":"2025","unstructured":"Mei X, Fobian SF, Crezee MIJ, van Bochove J, van Lonkhuijzen GGW (2025) High human papillomavirus viral load and local immune dysregulation are associated with poor clinical outcomes in patients with cervical cancer. Int J Gynecol Cancer 35(7):101924","journal-title":"Int J Gynecol Cancer"},{"key":"2440_CR3","doi-asserted-by":"publisher","first-page":"104249","DOI":"10.1016\/j.critrevonc.2023.104249","volume":"194","author":"M Samare-Najaf","year":"2024","unstructured":"Samare-Najaf M, Samareh A, Savardashtaki A, Khajehyar N, Tajbakhsh A, Vakili S et al (2024) Non-apoptotic cell death programs in cervical cancer with an emphasis on ferroptosis. Crit Rev Oncol Hematol 194:104249","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"2440_CR4","doi-asserted-by":"publisher","first-page":"100199","DOI":"10.1016\/j.mocell.2025.100199","volume":"48","author":"MJ Morgan","year":"2025","unstructured":"Morgan MJ, Kim YS (2025) RIPK3 in necroptosis and cancer. Mol Cells 48(5):100199","journal-title":"Mol Cells"},{"issue":"2","key":"2440_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrm3737","volume":"15","author":"TV Berghe","year":"2014","unstructured":"Berghe TV, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P (2014) Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 15(2):135\u2013147","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"2440_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrm2970","volume":"11","author":"P Vandenabeele","year":"2010","unstructured":"Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11(10):700\u2013714","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"14","key":"2440_CR7","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1111\/febs.13520","volume":"283","author":"A Oberst","year":"2016","unstructured":"Oberst A (2016) Death in the fast lane: What\u2019s next for necroptosis? Febs J 283(14):2616\u20132625","journal-title":"Febs j"},{"issue":"7338","key":"2440_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nature09852","volume":"471","author":"A Oberst","year":"2011","unstructured":"Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C et al (2011) Catalytic activity of the caspase-8\u2013FLIPL complex inhibits RIPK3-dependent necrosis. Nature 471(7338):363\u2013367","journal-title":"Nature"},{"issue":"6","key":"2440_CR9","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1007\/s12094-024-03769-x","volume":"27","author":"Y He","year":"2025","unstructured":"He Y, Wang X (2025) A comprehensive investigation of associations between cell death pathways and molecular and clinical features in pan-cancer. Clin Transl Oncol 27(6):2731\u20132749","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"2440_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41419-022-05066-3","volume":"13","author":"G Zhang","year":"2022","unstructured":"Zhang G, Wang J, Zhao Z, Xin T, Fan X, Shen Q et al (2022) Regulated necrosis, a proinflammatory cell death, potentially counteracts pathogenic infections. Cell Death Dis 13(7):637","journal-title":"Cell Death Dis"},{"issue":"2","key":"2440_CR11","first-page":"259","volume":"1871","author":"X Qin","year":"2019","unstructured":"Qin X, Ma D, Tan Y-x, Wang H-y, Cai Z (2019) The role of necroptosis in cancer: A double-edged sword? Biochimica et Biophysica Acta (BBA) -. Reviews Cancer 1871(2):259\u2013266","journal-title":"Reviews Cancer"},{"issue":"5","key":"2440_CR12","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1002\/mco2.343","volume":"4","author":"L Wang","year":"2023","unstructured":"Wang L, Geng H, Liu Y, Liu L, Chen Y, Wu F et al (2023) Hot and cold tumors: immunological features and the therapeutic strategies. MedComm (2020) 4(5):e343","journal-title":"MedComm (2020)"},{"key":"2440_CR13","doi-asserted-by":"publisher","first-page":"102455","DOI":"10.1016\/j.coi.2024.102455","volume":"89","author":"J Yin","year":"2024","unstructured":"Yin J, Yu Y, Huang X, Chan FK (2024) Necroptosis in immunity, tissue homeostasis, and cancer. Curr Opin Immunol 89:102455","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"2440_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12964-023-01417-5","volume":"22","author":"S Zhang","year":"2024","unstructured":"Zhang S, Liu Y, Ma X, Gao X, Ru Y, Hu X et al (2024) Recent advances in the potential role of RNA N4-acetylcytidine in cancer progression. Cell Commun Signal 22(1):49","journal-title":"Cell Communication Signal"},{"issue":"2","key":"2440_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2174\/0929866530666230104155209","volume":"30","author":"Z Wei","year":"2023","unstructured":"Wei Z, Haixia M, Jing C, Chunjie W, Li H (2023) Circ_0002762 regulates oncoprotein YBX1 in cervical cancer via mir-375 to regulate the malignancy of cancer cells. Protein Pept Lett 30(2):162\u2013172","journal-title":"Protein Pept Lett"},{"key":"2440_CR16","doi-asserted-by":"publisher","first-page":"892813","DOI":"10.3389\/fonc.2022.892813","volume":"12","author":"T Oltean","year":"2022","unstructured":"Oltean T, Lippens L, Lemeire K, De Tender C, Vuylsteke M, Denys H et al (2022) Association of cell death markers with tumor immune cell infiltrates after chemo-radiation in cervical cancer. Front Oncol 12:892813","journal-title":"Front Oncol"},{"key":"2440_CR17","doi-asserted-by":"crossref","unstructured":"Wang S, He H, Qu L, Shen Q, Dai Y (2024) Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis. Front Pharmacol 15:1446486","DOI":"10.3389\/fphar.2024.1446486"},{"issue":"10","key":"2440_CR18","doi-asserted-by":"publisher","first-page":"e3084","DOI":"10.1038\/cddis.2017.483","volume":"8","author":"C Yang","year":"2017","unstructured":"Yang C, Li J, Yu L, Zhang Z, Xu F, Jiang L et al (2017) Regulation of RIP3 by the transcription factor Sp1 and the epigenetic regulator UHRF1 modulates cancer cell necroptosis. Cell Death Dis 8(10):e3084\u2013e","journal-title":"Cell Death Dis"},{"issue":"11","key":"2440_CR19","first-page":"15035","volume":"8","author":"J Ruan","year":"2015","unstructured":"Ruan J, Mei L, Zhu Q, Shi G, Wang H (2015) Mixed lineage kinase domain-like protein is a prognostic biomarker for cervical squamous cell cancer. Int J Clin Exp Pathol 8(11):15035\u201315038","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"2440_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000487434","volume":"83","author":"L Li","year":"2018","unstructured":"Li L, Yu S, Zang C (2018) Low necroptosis process predicts poor treatment outcome of human papillomavirus positive cervical cancers by decreasing tumor-associated macrophages m1 polarization. Gynecol Obstet Invest 83(3):259\u2013267","journal-title":"Gynecol Obstet Invest"},{"key":"2440_CR21","doi-asserted-by":"publisher","first-page":"1110939","DOI":"10.3389\/fonc.2023.1110939","volume":"13","author":"TLR Vogelsang","year":"2023","unstructured":"Vogelsang TLR, Kast V, Bagnjuk K, Eubler K, Jeevanandan SP, Schmoeckel E et al (2023) RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation in vitro. Front Oncol 13:1110939","journal-title":"Front Oncol"},{"key":"2440_CR22","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3389\/fonc.2020.01720","volume":"10","author":"KJ Wang","year":"2020","unstructured":"Wang KJ, Wang KY, Zhang HZ, Meng XY, Chen JF, Wang P et al (2020) Up-regulation of RIP3 alleviates prostate cancer progression by activation of RIP3\/MLKL signaling pathway and induction of necroptosis. Front Oncol 10:1720","journal-title":"Front Oncol"},{"issue":"29","key":"2440_CR23","doi-asserted-by":"publisher","first-page":"46384","DOI":"10.18632\/oncotarget.10135","volume":"7","author":"D Bozec","year":"2016","unstructured":"Bozec D, Iuga AC, Roda G, Dahan S, Yeretssian G (2016) Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis. Oncotarget 7(29):46384","journal-title":"Oncotarget"},{"key":"2440_CR24","doi-asserted-by":"crossref","unstructured":"Fernando W, Clucas J, Rizzo A, Singer R, Goode E, Tiu C et al (2026) Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy. Nat Commun17:3597","DOI":"10.1038\/s41467-026-70133-8"},{"issue":"8","key":"2440_CR25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41422-018-0058-y","volume":"28","author":"D Jiao","year":"2018","unstructured":"Jiao D, Cai Z, Choksi S, Ma D, Choe M, Kwon H-J et al (2018) Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis. Cell Res 28(8):868\u2013870","journal-title":"Cell Res"},{"issue":"17","key":"2440_CR26","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.3390\/cancers13174473","volume":"13","author":"T Yamauchi","year":"2021","unstructured":"Yamauchi T, Fujishima F, Hashimoto M, Tsunokake J, Akaishi R, Gokon Y et al (2021) Necroptosis in esophageal squamous cell carcinoma: an independent prognostic factor and its correlation with tumor-infiltrating lymphocytes. Cancers 13(17):4473","journal-title":"Cancers"},{"issue":"1","key":"2440_CR27","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1038\/s41467-024-50450-6","volume":"15","author":"C-Y Liao","year":"2024","unstructured":"Liao C-Y, Li G, Kang F-P, Lin C-F, Xie C-K, Wu Y-D et al (2024) Necroptosis enhances \u2018don\u2019t eat me\u2019 signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis. Nat Commun 15(1):6043","journal-title":"Nat Commun"},{"key":"2440_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.18632\/oncotarget.28404","volume":"14","author":"Z Liu","year":"2023","unstructured":"Liu Z, Choksi S, Liu ZG (2023) Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity. Oncotarget 14:295\u2013296","journal-title":"Oncotarget"},{"key":"2440_CR29","doi-asserted-by":"crossref","unstructured":"Hsu SK, Chang WT, Lin IL, Chen YF, Padalwar NB, Cheng KC et al (2020) The role of necroptosis in ROS-mediated cancer therapies and its promising applications. Cancers (Basel) 12(8) :2185","DOI":"10.3390\/cancers12082185"},{"issue":"1","key":"2440_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31\u201346","journal-title":"Cancer Discov"},{"issue":"6","key":"2440_CR31","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","volume":"137","author":"S He","year":"2009","unstructured":"He S, Wang L, Miao L, Wang T, Du F, Zhao L et al (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137(6):1100\u20131111","journal-title":"Cell"},{"issue":"10","key":"2440_CR32","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/s12276-022-00868-z","volume":"54","author":"MJ Morgan","year":"2022","unstructured":"Morgan MJ, Kim YS (2022) Roles of RIPK3 in necroptosis, cell signaling, and disease. Exp Mol Med 54(10):1695\u20131704","journal-title":"Exp Mol Med"},{"issue":"6","key":"2440_CR33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/cr.2015.56","volume":"25","author":"G-B Koo","year":"2015","unstructured":"Koo G-B, Morgan MJ, Lee D-G, Kim W-J, Yoon J-H, Koo JS et al (2015) Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res 25(6):707\u2013725","journal-title":"Cell Res"},{"issue":"2","key":"2440_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.tranon.2019.11.011","volume":"13","author":"Q Wang","year":"2020","unstructured":"Wang Q, Wang P, Zhang L, Tessema M, Bai L, Xu X et al (2020) Epigenetic regulation of RIP3 suppresses necroptosis and increases resistance to chemotherapy in nonsmall cell lung cancer. Transl Oncol 13(2):372\u2013382","journal-title":"Transl Oncol"},{"issue":"32","key":"2440_CR35","doi-asserted-by":"publisher","first-page":"e2204522","DOI":"10.1002\/advs.202204522","volume":"9","author":"SM Hwang","year":"2022","unstructured":"Hwang SM, Ha YJ, Koo GB, Noh HJ, Lee AY, Kim BJ et al (2022) LCK-mediated RIPK3 activation controls double-positive thymocyte proliferation and restrains thymic lymphoma by regulating the PP2A-ERK axis. Adv Sci (Weinh) 9(32):e2204522","journal-title":"Adv Sci (Weinh)"},{"issue":"16","key":"2440_CR36","doi-asserted-by":"publisher","first-page":"eadi1782","DOI":"10.1126\/sciadv.adi1782","volume":"10","author":"S Zhu","year":"2024","unstructured":"Zhu S, Luo Y, Li K, Mei C, Wang Y, Jiang L et al (2024) RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells. Sci Adv 10(16):eadi1782","journal-title":"Sci Adv"},{"issue":"1","key":"2440_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","volume":"18","author":"Y Gong","year":"2019","unstructured":"Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K et al (2019) The role of necroptosis in cancer biology and therapy. Mol Cancer 18(1):100","journal-title":"Mol Cancer"},{"key":"2440_CR38","doi-asserted-by":"crossref","unstructured":"Sax A, May P, Enssle S, Soliman N, Nedelko T, Mandracci G et al (2025) Defects in the necroptosis machinery are a cancer resistance mechanism to checkpoint inhibitor immunotherapy. J Immunother Cancer13(5):e010433","DOI":"10.1136\/jitc-2024-010433"},{"issue":"17","key":"2440_CR39","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.3390\/ijms20174254","volume":"20","author":"L Van Hoecke","year":"2019","unstructured":"Van Hoecke L, Raes L, Stremersch S, Brans T, Fraire JC, Roelandt R et al (2019) Delivery of mixed-lineage kinase domain-like protein by vapor nanobubble photoporation induces necroptotic-like cell death in tumor cells. Int J Mol Sci 20(17):4254","journal-title":"Int J Mol Sci [Internet]"},{"issue":"6","key":"2440_CR40","doi-asserted-by":"publisher","first-page":"e29741","DOI":"10.1002\/jmv.29741","volume":"96","author":"SF Fobian","year":"2024","unstructured":"Fobian SF, Mei X, Crezee J, Snoek BC, Steenbergen RDM, Hu J et al (2024) Increased human papillomavirus viral load is correlated to higher severity of cervical disease and poorer clinical outcome: A systematic review. J Med Virol 96(6):e29741","journal-title":"J Med Virol"},{"issue":"1","key":"2440_CR41","first-page":"22","volume":"31","author":"X Zhou","year":"2026","unstructured":"Zhou X, An R, Li X (2026) Cervical cancer immune microenvironment: mechanisms of HPV-mediated immune evasion and advances in immunotherapy (Review). Oncol Lett 31(1):22","journal-title":"Oncol Lett"},{"issue":"19","key":"2440_CR42","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1158\/1078-0432.CCR-24-0385","volume":"30","author":"E Bonfill-Teixidor","year":"2024","unstructured":"Bonfill-Teixidor E, Neva-Alejo A, Arias A, Cuartas I, Iurlaro R, Planas-Rigol E et al (2024) Cervical cancer evades the host immune system through the inhibition of type I interferon and CXCL9 by LIF. Clin Cancer Res 30(19):4505\u20134516","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2440_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12307-011-0066-7","volume":"4","author":"SJ Piersma","year":"2011","unstructured":"Piersma SJ (2011) Immunosuppressive tumor microenvironment in cervical cancer patients. Cancer Microenviron 4(3):361\u2013375","journal-title":"Cancer Microenviron"},{"key":"2440_CR44","doi-asserted-by":"crossref","unstructured":"Sprooten J, De Wijngaert P, Vanmeerbeerk I, Martin S, Vangheluwe P, Schlenner S et al (2020) Necroptosis in immuno-oncology and cancer immunotherapy. Cells 9(8) :1823","DOI":"10.3390\/cells9081823"},{"issue":"1","key":"2440_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12672-022-00477-2","volume":"13","author":"J Ma","year":"2022","unstructured":"Ma J, Jin Y, Gong B, Li L, Zhao Q (2022) Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance. Discov Oncol 13(1):17","journal-title":"Discov Oncol"},{"key":"2440_CR46","doi-asserted-by":"publisher","first-page":"938250","DOI":"10.3389\/fgene.2022.938250","volume":"13","author":"X Du","year":"2022","unstructured":"Du X, Pu X, Wang X, Zhang Y, Jiang T, Ge Y et al (2022) A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer. Front Genet 13:938250","journal-title":"Front Genet"},{"issue":"6","key":"2440_CR47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.22514\/ejgo.2024.116","volume":"45","author":"Y Du","year":"2024","unstructured":"Du Y, Hu Y, Qiu M, Sheng Y (2024) Necroptosis-related gene to construct a signature to predict the prognosis and immune features in patients with cervical cancer. Eur J Gynaecol Oncol 45(6):48\u201366","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"2440_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3892\/mco.2024.2747","volume":"21","author":"L Guo","year":"2024","unstructured":"Guo L, Ma X, Li H, Yan S, Zhang K, Li J (2024) Single\u2013cell RNA\u2013seq necroptosis\u2013related genes predict the prognosis of breast cancer and affect the differentiation of CD4(+) T cells in tumor immune microenvironment. Mol Clin Oncol 21(1):49","journal-title":"Mol Clin Oncol"},{"issue":"14","key":"2440_CR49","doi-asserted-by":"publisher","first-page":"12947","DOI":"10.1007\/s00432-023-05158-3","volume":"149","author":"X Kong","year":"2023","unstructured":"Kong X, Xiong Y (2023) A novel necroptosis-related long non-coding RNA signature predicts prognosis and immune response in cervical cancer patients. J Cancer Res Clin Oncol 149(14):12947\u201312964","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2440_CR50","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12876-022-02423-6","volume":"22","author":"K Sun","year":"2022","unstructured":"Sun K, Hong JJ, Chen DM, Luo ZX, Li JZ (2022) Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma. BMC Gastroenterol 22(1):344","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"2440_CR51","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12957-022-02802-z","volume":"20","author":"K Sun","year":"2022","unstructured":"Sun K, Huang C, Li JZ, Luo ZX (2022) Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification. World J Surg Oncol 20(1):342","journal-title":"World J Surg Oncol"},{"key":"2440_CR52","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.2147\/IJGM.S366925","volume":"15","author":"J Zhan","year":"2022","unstructured":"Zhan J, Yang F, Ge C, Yu X (2022) Multi-omics approaches identify necroptosis\u2013related prognostic signature and associated regulatory axis in cervical cancer. Int J Gen Med 15:4937\u20134948","journal-title":"Int J Gen Med"},{"key":"2440_CR53","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"2440_CR54","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson j, Welch V, Losos M et al (2000) The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 4447"},{"issue":"6","key":"2440_CR55","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s43032-022-01155-y","volume":"30","author":"Z Yang","year":"2023","unstructured":"Yang Z, Li J, Tang Y, Zou L (2023) Identification and validation a necroptosis-related prognostic signature in cervical cancer. Reprod Sci 30(6):2003\u20132015","journal-title":"Reprod Sci"},{"key":"2440_CR56","doi-asserted-by":"publisher","first-page":"1061107","DOI":"10.3389\/fgene.2022.1061107","volume":"13","author":"X Xing","year":"2022","unstructured":"Xing X, Tian Y, Jin X (2022) Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer. Front Genet 13:1061107","journal-title":"Front Genet"},{"key":"2440_CR57","doi-asserted-by":"publisher","first-page":"107656","DOI":"10.1016\/j.compbiomed.2023.107656","volume":"168","author":"T Xu","year":"2024","unstructured":"Xu T, Jiang J, Xiang X, Jahanshahi H, Zhang Y, Chen X et al (2024) Conduction and validation of a novel prognostic signature in cervical cancer based on the necroptosis characteristic genes via integrating of multiomics data. Comput Biol Med 168:107656","journal-title":"Comput Biol Med"},{"issue":"1","key":"2440_CR58","doi-asserted-by":"publisher","first-page":"16773","DOI":"10.1038\/s41598-022-20566-0","volume":"12","author":"J Zou","year":"2022","unstructured":"Zou J, Lin Z, Jiao W, Chen J, Lin L, Zhang F et al (2022) A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma. Sci Rep 12(1):16773","journal-title":"Sci Rep"},{"key":"2440_CR59","doi-asserted-by":"publisher","first-page":"1011000","DOI":"10.3389\/fonc.2022.1011000","volume":"12","author":"W Zhang","year":"2022","unstructured":"Zhang W, Cao W, Tong Z, Jin Q, Jiang X, Yang Y et al (2022) Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma. Front Oncol 12:1011000","journal-title":"Front Oncol"},{"key":"2440_CR60","doi-asserted-by":"publisher","first-page":"6718443","DOI":"10.1155\/2021\/6718443","volume":"2021","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Liu H, Zhou X, Fang D, Ou X, Ye J et al (2021) Necroptosis-related lncRNAs: predicting prognosis and the distinction between the cold and hot tumors in gastric cancer. J Oncol 2021:6718443","journal-title":"J Oncol"},{"issue":"1","key":"2440_CR61","doi-asserted-by":"publisher","first-page":"16285","DOI":"10.1038\/s41598-022-20858-5","volume":"12","author":"Z Lin","year":"2022","unstructured":"Lin Z, Zou J, Sui X, Yao S, Lin L, Wang J et al (2022) Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas. Sci Rep 12(1):16285","journal-title":"Sci Rep"},{"issue":"5","key":"2440_CR62","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.21037\/tcr-23-578","volume":"12","author":"S Guo","year":"2023","unstructured":"Guo S, Bai W, Gu X, Li Y, Yang B, Ma S et al (2023) Clinicopathological and prognosis significance of RIPK1 in patients with cervical squamous cell carcinoma: a retrospective cohort study. Transl Cancer Res 12(5):1315\u20131324","journal-title":"Transl Cancer Res"},{"key":"2440_CR63","doi-asserted-by":"crossref","unstructured":"Vogelsang TLR, Schmoeckel E, Topalov NE, Ganster F, Mahner S, Jeschke U et al (2024) Prognostic impact of heat shock protein 90 expression in women diagnosed with cervical cancer. Int J Mol Sci 25(3) :1571","DOI":"10.3390\/ijms25031571"},{"issue":"18","key":"2440_CR64","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","volume":"33","author":"JR Conway","year":"2017","unstructured":"Conway JR, Lex A, Gehlenborg N (2017) UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics 33(18):2938\u20132940","journal-title":"Bioinformatics"},{"issue":"D1","key":"2440_CR65","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R et al (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51(D1):D638\u2013d46","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2440_CR66","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/cdd.2016.102","volume":"24","author":"K Rohde","year":"2017","unstructured":"Rohde K, Kleinesudeik L, Roesler S, L\u00f6we O, Heidler J, Schr\u00f6der K et al (2017) A Bak-dependent mitochondrial amplification step contributes to Smac mimetic\/glucocorticoid-induced necroptosis. Cell Death Differ 24(1):83\u201397","journal-title":"Cell Death Differ"},{"issue":"9","key":"2440_CR67","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41556-024-01429-4","volume":"26","author":"HL Glover","year":"2024","unstructured":"Glover HL, Schreiner A, Dewson G, Tait SWG (2024) Mitochondria and cell death. Nat Cell Biol 26(9):1434\u20131446","journal-title":"Nat Cell Biol"},{"issue":"2","key":"2440_CR68","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41556-017-0022-y","volume":"20","author":"Z Yang","year":"2018","unstructured":"Yang Z, Wang Y, Zhang Y, He X, Zhong C-Q, Ni H et al (2018) RIP3 targets pyruvate dehydrogenase complex to increase aerobic respiration in TNF-induced necroptosis. Nat Cell Biol 20(2):186\u2013197","journal-title":"Nat Cell Biol"},{"issue":"5938","key":"2440_CR69","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.1172308","volume":"325","author":"D-W Zhang","year":"2009","unstructured":"Zhang D-W, Shao J, Lin J, Zhang N, Lu B-J, Lin S-C et al (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325(5938):332\u2013336","journal-title":"Science"},{"issue":"3","key":"2440_CR70","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB (2022) The hallmarks of cancer metabolism: Still emerging. Cell Metab 34(3):355\u2013377","journal-title":"Cell Metab"},{"issue":"19","key":"2440_CR71","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3390\/cells13191666","volume":"13","author":"H Sabit","year":"2024","unstructured":"Sabit H, Arneth B, Abdel-Ghany S, Madyan EF, Ghaleb AH, Selvaraj P et al (2024) Beyond cancer cells: how the tumor microenvironment drives cancer progression. Cells 13(19):1666","journal-title":"Cells"},{"key":"2440_CR72","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jare.2025.05.055","volume":"81","author":"C-Y Lian","year":"2026","unstructured":"Lian C-Y, Xia W-H, Sun M-C, Wan X-M, Zhou X-L, Wang L (2026) Cadmium targeting MLKL-Drp1 axis to trigger mitochondrial oxidative stress contributes to necroinflammation in rat kidney. J Adv Res 81:1079\u20131093","journal-title":"J Adv Res"},{"key":"2440_CR73","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1600-065X.2008.00615.x","volume":"222","author":"RN Apte","year":"2008","unstructured":"Apte RN, Voronov E (2008) Is interleukin-1 a good or bad \u2018guy\u2019 in tumor immunobiology and immunotherapy? Immunol Rev 222:222\u2013241","journal-title":"Immunol Rev"},{"issue":"4","key":"2440_CR74","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.celrep.2013.10.034","volume":"5","author":"SWG Tait","year":"2013","unstructured":"Tait SWG, Oberst A, Quarato G, Milasta S, Haller M, Wang R et al (2013) Widespread mitochondrial depletion via mitophagy does not compromise necroptosis. Cell Rep 5(4):878\u2013885","journal-title":"Cell Rep"},{"issue":"10","key":"2440_CR75","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman I, Chen DS, Powles T, Turley SJ (2023) The cancer-immunity cycle: indication, genotype, and immunotype. Immunity 56(10):2188\u20132205","journal-title":"Immunity"},{"key":"2440_CR76","doi-asserted-by":"crossref","unstructured":"Burigotto M, Carlton JG (2025) ESCRT-III function in membrane fission and repair. Nat Rev Mol Cell Biol 27:297-315","DOI":"10.1038\/s41580-025-00909-1"},{"key":"2440_CR77","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jare.2025.01.040","volume":"77","author":"L Yu","year":"2025","unstructured":"Yu L, Guo Q, Li Y, Mao M, Liu Z, Li T et al (2025) CHMP4C promotes pancreatic cancer progression by inhibiting necroptosis via the RIPK1\/RIPK3\/MLKL pathway. J Adv Res 77:653\u2013668","journal-title":"J Adv Res"},{"key":"2440_CR78","doi-asserted-by":"publisher","first-page":"1170397","DOI":"10.3389\/fonc.2023.1170397","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Liu D, Qin Z, Yi B, Zhu L, Xu S et al (2023) CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy. Front Oncol 13:1170397","journal-title":"Front Oncol"},{"issue":"22","key":"2440_CR79","doi-asserted-by":"publisher","first-page":"12907","DOI":"10.18632\/aging.205210","volume":"15","author":"H-M Wu","year":"2023","unstructured":"Wu H-M, Ji K-J, He T-L, Duan Y-M, Zhang J-W, Hu G-Q (2023) The necroptosis signature and molecular mechanism of lung squamous cell carcinoma. Aging 15(22):12907\u201312926","journal-title":"Aging"},{"issue":"2","key":"2440_CR80","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neo.2020.12.006","volume":"23","author":"K Gong","year":"2021","unstructured":"Gong K, Guo G, Beckley N, Zhang Y, Yang X, Sharma M et al (2021) Tumor necrosis factor in lung cancer: complex roles in biology and resistance to treatment. Neoplasia 23(2):189\u2013196","journal-title":"Neoplasia"},{"issue":"10","key":"2440_CR81","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/cdd.2010.44","volume":"17","author":"BL Probst","year":"2010","unstructured":"Probst BL, Liu L, Ramesh V, Li L, Sun H, Minna JD et al (2010) Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-\u03b1-dependent manner. Cell Death Differ 17(10):1645\u20131654","journal-title":"Cell Death Differ"},{"issue":"1","key":"2440_CR82","doi-asserted-by":"publisher","first-page":"15696","DOI":"10.1038\/s41598-021-95160-x","volume":"11","author":"G Lan","year":"2021","unstructured":"Lan G, Yu X, Sun X, Li W, Zhao Y, Lan J et al (2021) Comprehensive analysis of the expression and prognosis for TNFAIPs in head and neck cancer. Sci Rep 11(1):15696","journal-title":"Sci Rep"},{"issue":"4","key":"2440_CR83","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3892\/ijo.2016.3662","volume":"49","author":"Z-W Tan","year":"2016","unstructured":"Tan Z-W, Xie S, Hu S-Y, Liao T, Liu P, Peng K-H et al (2016) Caudatin targets TNFAIP1\/NF-\u03baB and cytochrome c\/caspase signaling to suppress tumor progression in human uterine cancer. Int J Oncol 49(4):1638\u20131650","journal-title":"Int J Oncol"},{"issue":"4","key":"2440_CR84","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/carcin\/bgt001","volume":"34","author":"TY Shi","year":"2013","unstructured":"Shi TY, Cheng X, Yu KD, Sun MH, Shao ZM, Wang MY et al (2013) Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes. Carcinogenesis 34(4):770\u2013778","journal-title":"Carcinogenesis"},{"key":"2440_CR85","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fonc.2017.00060","volume":"7","author":"V Shoshan-Barmatz","year":"2017","unstructured":"Shoshan-Barmatz V, De S, Meir A (2017) The mitochondrial voltage-dependent anion channel 1, Ca(2+) transport, apoptosis, and their regulation. Front Oncol 7:60","journal-title":"Front Oncol"},{"key":"2440_CR86","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/978-3-319-29635-7_18","volume-title":"Vascular Ion Channels in Physiology and Disease","author":"A Truong","year":"2016","unstructured":"Truong A, Murugesan S, Youssef K, Makino A, PI L, MDPMA D (2016) Vascular ion channels in physiology and disease. Springer, New York City, pp 397\u2013419"},{"issue":"10","key":"2440_CR87","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/j.celrep.2016.02.030","volume":"14","author":"C C\u00e1rdenas","year":"2016","unstructured":"C\u00e1rdenas C, M\u00fcller M, McNeal A, Lovy A, Ja\u0148a F, Bustos G et al (2016) Selective vulnerability of cancer cells by inhibition of Ca2\u2009+\u2009transfer from endoplasmic reticulum to mitochondria. Cell Rep 14(10):2313\u20132324","journal-title":"Cell Rep"},{"issue":"12","key":"2440_CR88","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1074\/jbc.M115.691352","volume":"291","author":"AD Chaudhuri","year":"2016","unstructured":"Chaudhuri AD, Choi DC, Kabaria S, Tran A, Junn E (2016) MicroRNA-7 regulates the function of mitochondrial permeability transition pore by targeting VDAC1 expression. J Biol Chem 291(12):6483\u20136493","journal-title":"J Biol Chem"},{"issue":"7033","key":"2440_CR89","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nature03317","volume":"434","author":"T Nakagawa","year":"2005","unstructured":"Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H et al (2005) Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434(7033):652\u2013658","journal-title":"Nature"},{"issue":"1","key":"2440_CR90","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41420-022-00917-6","volume":"8","author":"L Wo","year":"2022","unstructured":"Wo L, Zhang X, Ma C, Zhou C, Li J, Hu Z et al (2022) LncRNA HABON promoted liver cancer cells survival under hypoxia by inhibiting mPTP opening. Cell Death Discov 8(1):171","journal-title":"Cell Death Discov"},{"key":"2440_CR91","doi-asserted-by":"publisher","first-page":"152049","DOI":"10.1016\/j.aanat.2023.152049","volume":"247","author":"H Wan","year":"2023","unstructured":"Wan H, Yan Y-d, Hu X-m, Shang L, Chen Y-h, Huang Y-x et al (2023) Inhibition of mitochondrial VDAC1 oligomerization alleviates apoptosis and necroptosis of retinal neurons following OGD\/R injury. Ann Anat - Anatomischer Anzeiger 247:152049","journal-title":"Annals Anat - Anatomischer Anzeiger"},{"issue":"1","key":"2440_CR92","doi-asserted-by":"publisher","first-page":"e23426","DOI":"10.1016\/j.heliyon.2023.e23426","volume":"10","author":"H Wan","year":"2024","unstructured":"Wan H, Yang YD, Zhang Q, Chen YH, Hu XM, Huang YX et al (2024) VDAC1, as a downstream molecule of MLKL, participates in OGD\/R-induced necroptosis by inducing mitochondrial damage. Heliyon 10(1):e23426","journal-title":"Heliyon"},{"issue":"11","key":"2440_CR93","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1007\/s10495-023-01887-5","volume":"28","author":"F Zhang","year":"2023","unstructured":"Zhang F, Qi C, Yao Z, Xu H, Zhou G, Li C et al (2023) Identification and validation of a novel necroptosis-related molecular signature to evaluate prognosis and immune features in breast cancer. Apoptosis 28(11):1628\u20131645","journal-title":"Apoptosis"},{"issue":"1","key":"2440_CR94","doi-asserted-by":"publisher","first-page":"15345","DOI":"10.1038\/s41598-023-41998-2","volume":"13","author":"G Wang","year":"2023","unstructured":"Wang G, Liu X, Liu H, Zhang X, Shao Y, Jia X (2023) A novel necroptosis related gene signature and regulatory network for overall survival prediction in lung adenocarcinoma. Sci Rep 13(1):15345","journal-title":"Sci Rep"},{"issue":"12","key":"2440_CR95","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.ccell.2024.10.014","volume":"42","author":"K H\u00e4nggi","year":"2024","unstructured":"H\u00e4nggi K, Li J, Gangadharan A, Liu X, Celias DP, Osunmakinde O et al (2024) Interleukin-1\u03b1 release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity. Cancer Cell 42(12):2015\u201331e11","journal-title":"Cancer Cell"},{"issue":"4","key":"2440_CR96","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1044-579X(02)00014-7","volume":"12","author":"RN Apte","year":"2002","unstructured":"Apte RN, Voronov E (2002) Interleukin-1\u2014a major pleiotropic cytokine in tumor\u2013host interactions. Sem Cancer Biol 12(4):277\u2013290","journal-title":"Sem Cancer Biol"},{"issue":"8","key":"2440_CR97","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.ccell.2021.04.011","volume":"39","author":"C Garlanda","year":"2021","unstructured":"Garlanda C, Mantovani A (2021) Interleukin-1 in tumor progression, therapy, and prevention. Cancer Cell 39(8):1023\u20131027","journal-title":"Cancer Cell"},{"issue":"4","key":"2440_CR98","first-page":"426","volume":"14","author":"L Tao","year":"2021","unstructured":"Tao L, Liu S, Xiong J, Yang H, Wu Y, Xu A et al (2021) IL-1\u03b2 promotes cervical cancer through activating NF-\u03baB\/CCL-2. Int J Clin Exp Pathol 14(4):426\u2013433","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"2440_CR99","doi-asserted-by":"publisher","first-page":"R421","DOI":"10.1530\/ERC-17-0309","volume":"25","author":"C Tulotta","year":"2018","unstructured":"Tulotta C, Ottewell P (2018) The role of IL-1B in breast cancer bone metastasis. Endocr Relat Cancer 25(7):R421\u2013r34","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"2440_CR100","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1158\/1078-0432.CCR-18-2202","volume":"25","author":"C Tulotta","year":"2019","unstructured":"Tulotta C, Lefley DV, Freeman K, Gregory WM, Hanby AM, Heath PR et al (2019) Endogenous production of IL1B by breast cancer cells drives metastasis and colonization of the bone microenvironment. Clin Cancer Res 25(9):2769\u20132782","journal-title":"Clin Cancer Res"},{"key":"2440_CR101","doi-asserted-by":"crossref","unstructured":"Zhang S, Liu S, Lin Z, Zhang J, Lin Z, Fang H et al (2022) Development and validation of a prognostic model for esophageal adenocarcinoma based on necroptosis-related genes. Genes (Basel) 13(12) :2243","DOI":"10.3390\/genes13122243"},{"issue":"23","key":"2440_CR102","doi-asserted-by":"publisher","first-page":"15942","DOI":"10.1074\/jbc.M114.557561","volume":"289","author":"H England","year":"2014","unstructured":"England H, Summersgill HR, Edye ME, Rothwell NJ, Brough D (2014) Release of interleukin-1\u03b1 or interleukin-1\u03b2 depends on mechanism of cell death. J Biol Chem 289(23):15942\u201315950","journal-title":"J Biol Chem"},{"key":"2440_CR103","first-page":"153","volume-title":"Chapter 8 - The Oxidative Burst System in Amphioxus","author":"P Yang","year":"2016","unstructured":"Yang P, Huang S, Xu A (2016) In: Xu A (ed) Chapter 8 - The oxidative burst system in amphioxus. Academic, amphioxus immunity, pp 153\u2013165"},{"issue":"1","key":"2440_CR104","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1186\/s12885-019-6202-3","volume":"19","author":"SY Cho","year":"2019","unstructured":"Cho SY, Kim S, Son MJ, Kim G, Singh P, Kim HN et al (2019) Dual oxidase 1 and NADPH oxidase 2 exert favorable effects in cervical cancer patients by activating immune response. BMC Cancer 19(1):1078","journal-title":"BMC Cancer"},{"issue":"8","key":"2440_CR105","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1016\/S0021-9258(18)42768-8","volume":"267","author":"K Schulze-Osthoff","year":"1992","unstructured":"Schulze-Osthoff K, Bakker A, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 267(8):5317\u20135323","journal-title":"J Biol Chem"},{"issue":"1","key":"2440_CR106","doi-asserted-by":"publisher","first-page":"14329","DOI":"10.1038\/ncomms14329","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Su SS, Zhao S, Yang Z, Zhong C-Q, Chen X et al (2017) RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat Commun 8(1):14329","journal-title":"Nat Commun"},{"issue":"5","key":"2440_CR107","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.molcel.2007.04.021","volume":"26","author":"Y-S Kim","year":"2007","unstructured":"Kim Y-S, Morgan MJ, Choksi S, Liu Z-g (2007) TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 26(5):675\u2013687","journal-title":"Mol Cell"},{"issue":"5","key":"2440_CR108","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.freeradbiomed.2008.11.022","volume":"46","author":"T-Y Chen","year":"2009","unstructured":"Chen T-Y, Chi K-H, Wang J-S, Chien C-L, Lin W-W (2009) Reactive oxygen species are involved in FasL-induced caspase-independent cell death and inflammatory responses. Free Radic Biol Med 46(5):643\u2013655","journal-title":"Free Radic Biol Med"},{"issue":"14","key":"2440_CR109","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1096\/fj.05-3726com","volume":"19","author":"L Thon","year":"2005","unstructured":"Thon L, M\u00f6hlig H, Mathieu S, Lange A, Bulanova E, Winoto-Morbach S et al (2005) Ceramide mediates caspase-independent programmed cell death. FASEB J 19(14):1945\u20131956","journal-title":"FASEB J"},{"key":"2440_CR110","doi-asserted-by":"publisher","first-page":"960327121106606","DOI":"10.1177\/09603271211066066","volume":"41","author":"Z Erdogmus Ozgen","year":"2022","unstructured":"Erdogmus Ozgen Z, Erdinc M, Kelle \u0130, Erdinc L, Nergiz Y (2022) Protective effects of necrostatin-1 on doxorubicin-induced cardiotoxicity in rat heart. Hum Exp Toxicol 41:9603271211066066","journal-title":"Hum Exp Toxicol"},{"issue":"31","key":"2440_CR111","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.2174\/0113816128316870240610045550","volume":"30","author":"CM Cardador","year":"2024","unstructured":"Cardador CM, de Castro TB, de Castro RJA, Bocca AL, Camargo LC, Pacheco TA et al (2024) Doxorubicin-induced immunogenic cell death impairs tumor progression and distant metastasis in a 4T1 breast cancer tumor model. Curr Pharm Des 30(31):2493\u20132504","journal-title":"Curr Pharm Des"},{"issue":"1","key":"2440_CR112","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12885-025-13439-y","volume":"25","author":"D Wen","year":"2025","unstructured":"Wen D, Yan R, Zhang L, Zhang H, Chen X, Zhou J (2025) Screening of necroptosis-related genes and evaluating the prognostic capacity, clinical value, and the effect of their copy number variations in acute myeloid leukemia. BMC Cancer 25(1):71","journal-title":"BMC Cancer"},{"key":"2440_CR113","doi-asserted-by":"crossref","unstructured":"Ling C, Zhou X, Gao Y, Sui X (2022) Identification of immune subtypes of esophageal adenocarcinoma to predict prognosis and immunotherapy response. Pharmaceuticals (Basel) 15(5) :605","DOI":"10.3390\/ph15050605"},{"issue":"1","key":"2440_CR114","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1186\/s12967-025-06896-3","volume":"23","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Liu M, An Y, Gao C, Wang T, Zhang Z et al (2025) Targeting immune microenvironment in cervical cancer: current research and advances. J Transl Med 23(1):888","journal-title":"J Transl Med"},{"key":"2440_CR115","doi-asserted-by":"crossref","unstructured":"Palabiyik AA (2025) The role of Bcl\u20132 in controlling the transition between autophagy and apoptosis (Review). Mol Med Rep 32(1) :172","DOI":"10.3892\/mmr.2025.13537"},{"key":"2440_CR116","doi-asserted-by":"crossref","unstructured":"Snyder AG, Hubbard NW, Messmer MN, Kofman SB, Hagan CE, Orozco SL et al (2019) Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity. Sci Immunol 4(36) :eaaw2004","DOI":"10.1126\/sciimmunol.aaw2004"},{"issue":"5","key":"2440_CR117","doi-asserted-by":"publisher","first-page":"115724","DOI":"10.1016\/j.isci.2026.115724","volume":"29","author":"Y Wu","year":"2026","unstructured":"Wu Y, Yu H, Zhang Z, Xiong W, Zeng Z, Liu W et al (2026) Inhibiting MDM2 enhances RIPK3-mediated necroptosis and synergizes with immune checkpoint blockade therapy. iScience 29(5):115724","journal-title":"iScience"},{"issue":"4","key":"2440_CR118","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.7150\/ijbs.121690","volume":"22","author":"X Zhang","year":"2026","unstructured":"Zhang X, Zhang D, Zhou Z, Liu W, Zhu S, Xiong S et al (2026) Targeted induction of cancer cell necroptosis potentiates Anti-PD-1 immunotherapy via CD80 activation. Int J Biol Sci 22(4):2085\u20132100","journal-title":"Int J Biol Sci"},{"key":"2440_CR119","doi-asserted-by":"publisher","first-page":"118988","DOI":"10.1016\/j.biopha.2026.118988","volume":"195","author":"C Zhang","year":"2026","unstructured":"Zhang C, Wang X, Miao Z, Shi T (2026) Unleashing necroptosis: transforming the tumor immune microenvironment for cancer therapy. Biomed Pharmacother 195:118988","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2440_CR120","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41420-026-03002-4","volume":"12","author":"J Liang","year":"2026","unstructured":"Liang J, Tan C, Li X, Fan J, Liu B (2026) Programmed cell death in cancer: targeting necroptosis to kill tumor cell. Cell Death Discovery 12(1):239","journal-title":"Cell Death Discovery"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02440-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02440-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02440-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:02:12Z","timestamp":1791748932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02440-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,11]]},"references-count":120,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2440"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02440-w","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,11]]},"assertion":[{"value":"25 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"244"}}